Related Experiment Video
Updated: Oct 1, 2026

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
[Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis]
Takashi Itoh1, Miwa Uzuki, Tadashi Shimamura
1Department of 1st Pathology, Department of Orthopedic Surgery, School of Medicine, Iwate Medical University, Morioka-city.
Objective:
Matrix metalloproteinase (MMP) is a novel proteolytic enzyme that plays an important role in joint destruction in rheumatoid arthritis (RA). To elucidate the dynamics of MMPs in serum and synovial fluid, we measured the concentration and activity of MMP-1, -9, -13 in serum and synovial fluid of RA patients. Among them especially we focused on newly defined MMP-13 and compared with MMP-1 and MMP-9.
Methods:
Serum, synovial fluid and synovial, and pannus tissues used in this study were obtained from RA patients. To compare the dynamics of each enzymic protein, we performed the following procedures: Firstly, we measured concentration of MMP-1, -9, -13 by using ELISA kit. Secondly, the activity of MMP-1, -9, -13 were also measured by using the MMP activity assay system. Then we obtained the activity ratio of each MMP from calculation of activity/concentration. We also examined the expression of MMP-13 in synovial tissues by immunohistochemical and in situ hybridization studies.
Result:
Concentration and activity levels of MMP-1, -9, -13 were significantly higher in RA serum and synovial fluid than in OA. Activity ratio of MMP-1, MMP-9 MMP-13 were 3.60 +/- 1.56, 1.03 +/- 1.75, 35.30 +/- 24.28 (ODA450/ng) in RA serum and 1.60 +/- 2.02, 3.97 +/- 14.83, 14.25 +/- 15.04 (ODA450/ng) in synovial fluid. In synovial and pannus tissues. MMP-13 positive cells were diffusely demonstrated by immunohistochemical and in situ hybridization studies. They were synovial lining cells, endothelial cells, fibroblasts, monocytes, osteoblasts, and chondrocytes.
Conclusion:
MMP-13 positive cells were diffusely presented in joint regions including synovial and pannus tissues. Although the concentration of MMP-13 was not so high, its activity ratio was elevated in serum and synovial fluid in the patients with rheumatoid arthritis.
Insights
Matrix metalloproteinases (MMPs) are key in rheumatoid arthritis (RA) joint destruction. This study found elevated MMP-13 activity in RA patients, highlighting its role in disease pathogenesis.
Area of Science:
- Biochemistry
- Immunology
- Rheumatology
Context:
- Rheumatoid arthritis (RA) is characterized by joint destruction.
- Matrix metalloproteinases (MMPs) are implicated in RA pathogenesis.
- MMP-13 is a newly defined enzyme with a significant role in joint destruction.
Purpose:
- To measure the concentration and activity of MMP-1, MMP-9, and MMP-13 in serum and synovial fluid of RA patients.
- To compare the dynamics of MMP-1, MMP-9, and MMP-13 in RA patients.
- To investigate the expression of MMP-13 in synovial tissues of RA patients.
Summary:
- Concentrations and activity levels of MMP-1, MMP-9, and MMP-13 were significantly higher in RA serum and synovial fluid compared to osteoarthritis (OA).
- The activity ratio of MMP-13 was notably elevated in RA serum and synovial fluid.
- MMP-13 positive cells were identified in synovial and pannus tissues, including synovial lining cells, endothelial cells, fibroblasts, monocytes, osteoblasts, and chondrocytes.
Impact:
- This study elucidates the dynamics of MMPs, particularly MMP-13, in rheumatoid arthritis.
- Findings suggest MMP-13 plays a crucial role in RA joint destruction.
- Elevated MMP-13 activity in RA patients offers potential therapeutic targets.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
The JAK-STAT Signaling Pathway